BioCentury | Apr 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

...II diabetes. Whitehead Institute for Biomedical Research Distillery Therapeutics Preclinical news Infectious disease Bacterial infection Neisseria meningitidis outer membrane protein PorA (N. meningitidis porA)...
BioCentury | Mar 27, 2018
Distillery Therapeutics

Infectious disease

INDICATION: Bacterial infection Chimeric antigens against N. meningitidis fHbp and N. meningitidis porA could be used to develop vaccines against serogroup B N. meningitidis infection. The antigens were generated by using a soluble N. meningitidis...
Items per page:
1 - 2 of 2